Pfizer Inc. buy BMO Capital Markets
Start price
02.05.24
/
50%
€25.92
Target price
02.05.25
€33.67
Performance (%)
-17.81%
End price
03.05.25
€21.30
Summary
This prediction ended on 03.05.25 with a price of €21.30. The prediction for Pfizer Inc. disappointed with a performance of -17.81%. Dividends of €1.58 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -0.457% | -0.457% | -5.830% |
| iShares Core DAX® | -3.809% | -1.472% | 6.060% |
| iShares Nasdaq 100 | 0.487% | 2.215% | 12.682% |
| iShares Nikkei 225® | -4.418% | 4.971% | 30.914% |
| iShares S&P 500 | 0.251% | 1.225% | 9.374% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $36.00 price target on the stock, up previously from $33.00.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten